Drug Type Small molecule drug |
Synonyms Glutathione (JP17), Glutathione (reduced type), Tathion + [1] |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (30 Jun 1967), |
Regulation- |
Molecular FormulaC10H17N3O6S |
InChIKeyRWSXRVCMGQZWBV-WDSKDSINSA-N |
CAS Registry70-18-8 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Drug intoxication | Japan | 22 Aug 1967 | |
| Heavy Metal Poisoning | Japan | 22 Aug 1967 | |
| Hypertension, Pregnancy-Induced | Japan | 22 Aug 1967 | |
| Vomiting of pregnancy | Japan | 22 Aug 1967 | |
| Chorioretinitis | Japan | 30 Jun 1967 | |
| Corneal Ulcer | Japan | 30 Jun 1967 | |
| Hyperpigmentation | Japan | 30 Jun 1967 | |
| Keratitis | Japan | 30 Jun 1967 | |
| Leukopenia | Japan | 30 Jun 1967 | |
| Stomatitis | Japan | 30 Jun 1967 | |
| Liver Diseases | China | - | - |
| Toxicity due to chemotherapy | China | - | - |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Atherosclerosis | Preclinical | South Korea | 13 Jun 2025 | |
| Endothelial dysfunction | Preclinical | South Korea | 13 Jun 2025 |
Phase 2 | 143 | C1-Inhibitor+Epoprostenol+Infliximab+Melatonin+Alfa-tocopherol+Human recombinant erythropoietin+Glutathione | rkdzmehkcr = grvoqipbar kfposzkgqe (pfehgcqiyp, iobtejtsca - xbbuygqhdi) View more | - | 23 Aug 2024 | ||
Phase 3 | Cystic Fibrosis First line | 94 | knxjeqxpkv(ovxogmatld) = wqzpkjqrxy prkohcbroo (jpedripajs ) | Positive | 01 Sep 2012 | ||
Placebo | knxjeqxpkv(ovxogmatld) = qhkopchves prkohcbroo (jpedripajs ) |





